
Conference Coverage
about 1 hour ago
Day 3 Recap: Elevate-Derm Fall Conferenceabout 4 hours ago
Treatment Plan Expectations and Previewing the 2026 Pipelineabout 6 hours ago
Expert Tips for Treating Vitiligo Shared at Elevate-Derm Conferenceabout 12 hours ago
Rosenblum Reveals New Fibroblast–Immune Axis in Skin InflammationLatest News

Day 3 Recap: Elevate-Derm Fall Conference

Treatment Plan Expectations and Previewing the 2026 Pipeline

Expert Tips for Treating Vitiligo Shared at Elevate-Derm Conference

Tips for Improving Rosacea Recognition in Patients With Skin of Color at Elevate-Derm

Sister Clinicians Highlight Cross-Specialty Collaboration in Dermatology and Podiatry

Shorts










Podcasts
Dermatology Times Digital Edition









Continuing Medical Education
All News

Michael Rosenblum’s team identified a previously underappreciated fibroblast subset that actively regulates inflammation, fibrosis, and microbial containment in the skin.

Therapeutic modulation of mitochondria offers a pathway to control multiple cytokine pathways simultaneously.

Catch up on coverage from the second day of the 2025 Elevate-Derm Fall Conference.

At the Elevate-Derm Fall Conference, Peter Lio, MD, highlighted practical strategies for corticosteroid stewardship, the expanding role of nonsteroidal topicals, and emerging opportunities in early-age indications that are reshaping pediatric inflammatory dermatoses care.

Baldwin discusses the latest advancements in acne and rosacea treatments, including innovative therapies and promising clinical trials.

Chronic itching can reflect systemic disease, highlighting the importance of comprehensive assessment.

Douglas DiRuggiero receives the prestigious Stead Silver Ford Honorary Award, celebrating his dedication and impact in dermatology and medical education.

Robert Bissonnette, MD, presented tape-strip transcriptomics detecting meaningful steroid responses after just 1 day of therapy.

At Elevate-Derm Fall, Victoria Garcia-Albea, NP, details the expanding educational landscape in hair disease management, the rise of dedicated hair health meetings, and practical pathways for clinicians looking to advance professionally through writing.

Researchers are developing an innovative mRNA vaccine targeting Merkel cell carcinoma, enhancing T cell immunity and offering new hope for effective treatment.

Victoria Garcia-Albea, NP, outlined evolving therapeutic strategies at Elevate-Derm Fall, highlighting low-dose oral minoxidil, off-label JAK inhibition for frontal fibrosing alopecia, Thiamidol in hyperpigmentation, and delgocitinib for chronic hand eczema.

Kim explores the significance of inflammation in dermatology, revealing its connections to various diseases and the importance of focused research.

Arcutis advances pediatric atopic dermatitis treatment with roflumilast cream, completing enrollment in key INTEGUMENT-INFANT trial.

A poster presented at Elevate-Derm found dupilumab significantly enhanced growth and reduces corticosteroid use in children with severe atopic dermatitis.






























